simendan has been researched along with Hypoplastic Left Heart Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Chiara, L; Di Molfetta, A; Haiberger, R; Iacobelli, R; Marinari, E; Ricci, Z; Toscano, A | 1 |
| Di Chiara, L; Di Donato, RM; Garisto, C; Giorni, C; Morelli, S; Picardo, S; Ricci, Z; Vitale, V | 1 |
1 trial(s) available for simendan and Hypoplastic Left Heart Syndrome
| Article | Year |
|---|---|
Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome.
Topics: Humans; Hydrazones; Hypoplastic Left Heart Syndrome; Infant, Newborn; Infusions, Intravenous; Pyridazines; Simendan; Vasodilator Agents | 2010 |
1 other study(ies) available for simendan and Hypoplastic Left Heart Syndrome
| Article | Year |
|---|---|
Effects of levosimendan on ventriculo-arterial coupling and cardiac efficiency in paediatric patients with single-ventricle physiology after surgical palliation: retrospective study.
Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Female; Heart Failure; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Retrospective Studies; Simendan; Stroke Volume; Univentricular Heart; Ventricular Function, Left | 2020 |